BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15336956)

  • 1. Calpain-related diseases.
    Branca D
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1098-104. PubMed ID: 15336956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpains in muscle wasting.
    Bartoli M; Richard I
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2115-33. PubMed ID: 16125114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpains and disease.
    Zatz M; Starling A
    N Engl J Med; 2005 Jun; 352(23):2413-23. PubMed ID: 15944426
    [No Abstract]   [Full Text] [Related]  

  • 4. Limb girdle muscular dystrophy in a sibling pair with a homozygous Ser606Leu mutation in the alternatively spliced IS2 region of calpain 3.
    Jenne DE; Kley RA; Vorgerd M; Schröder JM; Weis J; Reimann H; Albrecht B; Nürnberg P; Thiele H; Müller CR; Meng G; Witt CC; Labeit S
    Biol Chem; 2005 Jan; 386(1):61-7. PubMed ID: 15843148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calpain 3: a key regulator of the sarcomere?
    Duguez S; Bartoli M; Richard I
    FEBS J; 2006 Aug; 273(15):3427-36. PubMed ID: 16884488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene.
    Sáenz A; Leturcq F; Cobo AM; Poza JJ; Ferrer X; Otaegui D; Camaño P; Urtasun M; Vílchez J; Gutiérrez-Rivas E; Emparanza J; Merlini L; Paisán C; Goicoechea M; Blázquez L; Eymard B; Lochmuller H; Walter M; Bonnemann C; Figarella-Branger D; Kaplan JC; Urtizberea JA; Martí-Massó JF; López de Munain A
    Brain; 2005 Apr; 128(Pt 4):732-42. PubMed ID: 15689361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limb-girdle muscular dystrophy type 2A can result from accelerated autoproteolytic inactivation of calpain 3.
    Garnham CP; Hanna RA; Chou JS; Low KE; Gourlay K; Campbell RL; Beckmann JS; Davies PL
    Biochemistry; 2009 Apr; 48(15):3457-67. PubMed ID: 19226146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A.
    Groen EJ; Charlton R; Barresi R; Anderson LV; Eagle M; Hudson J; Koref MS; Straub V; Bushby KM
    Brain; 2007 Dec; 130(Pt 12):3237-49. PubMed ID: 18055493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain.
    Jia Z; Petrounevitch V; Wong A; Moldoveanu T; Davies PL; Elce JS; Beckmann JS
    Biophys J; 2001 Jun; 80(6):2590-6. PubMed ID: 11371436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations in the calpain 3 gene in Germany.
    Todorova A; Kress W; Mueller C
    Clin Genet; 2005 Apr; 67(4):356-8. PubMed ID: 15733273
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium-dependent proteolytic system and muscle dysfunctions: a possible role of calpains in sarcopenia.
    Dargelos E; Poussard S; Brulé C; Daury L; Cottin P
    Biochimie; 2008 Feb; 90(2):359-68. PubMed ID: 17881114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome.
    Chrobáková T; Hermanová M; Kroupová I; Vondrácek P; Maríková T; Mazanec R; Zámecník J; Stanek J; Havlová M; Fajkusová L
    Neuromuscul Disord; 2004 Oct; 14(10):659-65. PubMed ID: 15351423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A.
    Bartoli M; Roudaut C; Martin S; Fougerousse F; Suel L; Poupiot J; Gicquel E; Noulet F; Danos O; Richard I
    Mol Ther; 2006 Feb; 13(2):250-9. PubMed ID: 16290124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calpain-3 gene defect causing limb gird muscular dystrophy in a Hungarian family].
    Horváth R; Walter MC; Lochmüller H; Hübner A; Karcagi V; Pikó H; Timár L; Komoly S
    Ideggyogy Sz; 2005 Jan; 58(1-2):52-8. PubMed ID: 15884399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A.
    Anderson LV; Davison K; Moss JA; Richard I; Fardeau M; Tomé FM; Hübner C; Lasa A; Colomer J; Beckmann JS
    Am J Pathol; 1998 Oct; 153(4):1169-79. PubMed ID: 9777948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning of mouse canp3, the gene associated with limb-girdle muscular dystrophy 2A in human.
    Richard I; Beckmann JS
    Mamm Genome; 1996 May; 7(5):377-9. PubMed ID: 8661728
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies).
    Anderson LV; Harrison RM; Pogue R; Vafiadaki E; Pollitt C; Davison K; Moss JA; Keers S; Pyle A; Shaw PJ; Mahjneh I; Argov Z; Greenberg CR; Wrogemann K; Bertorini T; Goebel HH; Beckmann JS; Bashir R; Bushby KM
    Neuromuscul Disord; 2000 Dec; 10(8):553-9. PubMed ID: 11053681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A).
    Kramerova I; Beckmann JS; Spencer MJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):128-44. PubMed ID: 16934440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of genetic insights into calpain biology.
    Sorimachi H; Hata S; Ono Y
    J Biochem; 2011 Jul; 150(1):23-37. PubMed ID: 21610046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limb-girdle muscular dystrophy 2A.
    Gallardo E; Saenz A; Illa I
    Handb Clin Neurol; 2011; 101():97-110. PubMed ID: 21496626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.